Press release
Depression Treatment Therapy Market 2018 Growth, COVID Impact, Trends Analysis Report 2023
The depression treatment therapy market is estimated to grow moderately over the forecast period. Rapidly increasing cases of depression and innovations in drugs and therapies for anxiety disorders have been some of the primary drivers of the depression treatment therapy industry. Depression is growing to be one of the most significant contributors to the burden of diseases globally. Depression is affecting individuals all across the globe, with an estimated 350 million suffering from it, according to WHO (World Health Organization). According to a survey carried out in 17 countries by WHO, it was reported that on an average 1 in every 20 individuals had a depression event in 2017. The demand for restricting depression and other lethal mental health disorders is on the rise globally, which is fuelling the depression treatment therapy market.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/depression-treatment-market
The emerging organizations' investments for drug and therapy development in psychiatric disorders and depression seem to be at a significant incline over the last decade. Perseverance of this trend is expected to have positive implications for the future output of ground-breaking drugs and medicines in curing mental health disorder. However, there is still a significant unfulfilled need for new drugs and therapies for the treatment of mental health disorders. According to WHO, as of 2019, there are only 29 active approved substances for major depression since 1959. Additionally, a unique molecular target-based prospective new therapeutic approaches and procedures have witnessed a considerable number of setbacks. Presently, 33 drug programs are in clinical trials and using new therapeutic approaches for depression.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/depression-treatment-market
Recent investment levels, R&D trends, and depth of existing clinical pipeline could impede the way for future innovations in depression therapeutics. There has been a significant drop in clinical trial initiations over the last few years for novel drug candidates in depression. Enterprise expenditures into companies with depression focused programs have nearly non-existent over the past few years. Further, the limits of currently available drugs for depression imply thatfurther therapeutic choices are in demand to address patients' needs. This patient need presents a lucrative opportunity for organizations desiring to enter the depression treatment therapy market.
GlobalDepression Treatment Therapy Market - Segmentation
By Depression Type
Seasonal Affective Disorder (SAD)
Major Depression
Dysthymia Disorder
Postpartum Depression
Atypical Depression
Psychotic Depression
Bipolar Disorder
By Drugs Type
Selective Serotonin Reuptake Inhibitors
o Fluoxetine (Prozac)
o Sertraline (Zoloft)
o Escitalopram (Lexapro)
o Others Ssris
Atypical Antidepressants
o Bupropion (Wellbutrin)
o Duloxetine (Cymbalta)
o Venlafaxine (Effexor)
o Desvenlafaxine (Pristiq)
o Others Atypical Antidepressants
Tricyclic Antidepressants
By Depression Treatment Device
Transcranial Magnetic
Deep Brain Stimulator
Virtual Reality Therapy
Vagus Nerve Stimulator
Smart Phone Applications
Others Devices
GlobalDepression Treatment Therapy Market – Segment by Region
North America
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
COMPANY PROFILES
ABBOTT LABORATORIES
ALLERGAN PLC
ASTRAZENECA
BRAIN RESOURCE COMPANY (BRC)
BRAINSWAY LTD.
BRISTOL MYERS SQUIBB
CYBERONICS, INC
ELECTROMEDICAL PRODUCTS INTERNATIONAL, INC.
ELI LILLY AND COMPANY
JOHNSON & JOHNSON
LANNETT CO INC
LIFECARE NEURO PRODUCTS LIMITED
H. LUNDBECK A/S
MAGVENTURE
MAYO CLINIC
MERCK & CO.
NEUROSIGMA, INC.
NEURONETICS
NOVARTIS
OTSUKA PHARMACEUTICALS
PFIZER
ROCHE HOLDING AG
SANOFI-AVENTIS
SILVER OAK HEALTH
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICALS
TEVA PHARMACEUTICALS
THERAPY CHARLOTTE LLC
VALEANT PHARMACEUTICALS INTERNATIONAL
VISTAGEN THERAPEUTICS, INC.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/depression-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Depression Treatment Therapy Market 2018 Growth, COVID Impact, Trends Analysis Report 2023 here
News-ID: 2221687 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Depression
Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing D …
Ace Therapeutics released depression-related behavior tests to accelerate preclinical depression research.
New York, USA - December 24, 2024 - Ace Therapeutics, a preclinical contract research provider dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests [https://www.acetherapeutics.com/psychiatry/depression-behavior-tests.html] in its preclinical investigation processes. This integral development aims to enhance the understanding of depressive disorders and expedite…
Postpartum Depression Global Market Report 2024 - Postpartum Depression Market S …
The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The postpartum depression market…
Depression Apps Market - Tools for Resilience, Tools for Life: Depression Apps f …
Newark, New Castle, USA: The "Depression Apps Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Depression Apps Market: https://www.growthplusreports.com/report/depression-apps-market/8782
This latest report researches the industry structure, sales, revenue,…
Depression Apps Market - Navigating the Path to Mental Wellbeing: Harnessing the …
Newark, New Castle, USA - new report, titled Depression Apps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Depression Apps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Depression Apps market. The report offers an overview of the market, which…
Depression Treatment Device Market: Information by Product Type (Light Therapies …
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per…
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive…